Journal of Bone Oncology

Papers
(The TQCC of Journal of Bone Oncology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
#15. Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma168
Non-invasive MRI biomarkers for assessment of neoadjuvant chemotherapy response in osteosarcoma: Current techniques and clinical perspectives42
Postoperative outcomes of subaxial cervical spine metastasis: Comparison among the anterior, posterior, and combined approaches33
Real-life use of bone-targeting agents for bone metastases in France between 2009 and 2018: Results of the OPTIMOS study32
Senescence in the bone marrow microenvironment: A driver in development of therapy-related myeloid neoplasms31
MAT2A inhibits the ferroptosis in osteosarcoma progression regulated by miR-26b-5p26
Single Photon Emission Computed Tomography/X-ray Computed Tomography-based radiomics analysis for diagnosis of bone metastases in patients with breast cancer23
Macrophage heterogeneity in bone metastasis23
From bimodal to unimodal: The transformed incidence of osteosarcoma in the United States22
Lipid metabolic reprogramming and associated ferroptosis in osteosarcoma: From molecular mechanisms to potential targets22
Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw21
Demethylzeylasteral inhibits proliferation and metastasis of osteosarcoma cells by modulating the PI3K/AKT/Autophagy pathways21
State-of-the-art of minimally invasive treatments of bone metastases20
Radiomics model based on MRI to differentiate spinal multiple myeloma from metastases: A two-center study20
Predicting lung metastasis in high-grade osteosarcoma: The role of computed tomography angiography (CTA) signs with a focus on vascular wrapping and the intratumoral vascular network20
Preoperative prediction of high-grade osteosarcoma response to neoadjuvant therapy based on a plain CT radiomics model: A dual-center study19
#1. Acid ceramidase (ASAH1) is a key mediator of drug resistance in relapsed/refractory multiple myeloma19
A multicenter, randomized, double-blind trial comparing LY01011, a biosimilar, with denosumab (Xgeva®) in patients with bone metastasis from solid tumors19
Association of androgen receptor and tumour-infiltrating lymphocytes with bone recurrence in triple-negative breast cancer19
Questionable indication for postoperative radiotherapy after surgery for metastases of the major long bones: A single-centre cohort study of 552 fractures/526 patients19
#41. Discovery of novel tubulin code in bone metastasis of breast cancer18
Pain in patients with multiple inherited osteochondromas: Incidence and potential prognostic factors. A retrospective cohort study18
Pathological fractures as an adverse prognostic factor in chondrosarcoma: Results of a systematic review, meta-analysis and institutional case series17
Comprehensive landscape of TGFβ-related signature in osteosarcoma for predicting prognosis, immune characteristics, and therapeutic response17
#23. Elucidating the role of bone marrow stiffness in estrogen signaling in metastatic breast cancer to the bone17
Rotationplasty performed in adults versus minors: a comparative study of long-term quality of life, functional and biomechanical outcomes17
#49. Complete estrogen-deprived athymic nude mice are susceptible to changes in metabolism and musculoskeletal function mediated by a high-fat diet16
#2. Homing of intestinal NK and Th1 cells to the tumor site restrains melanoma bone growth in a gut microbiome dependent manner16
Intraosseous conventional central chondrosarcoma does not metastasise irrespective of grade in pelvis, scapula and in long bone locations16
#6. Mechanical loading of breast cancer laden bones alters osteocyte mediated bone loss in vivo16
Zoledronic acid in metastatic castrate-sensitive prostate cancer: A state-of-the-art review16
#31. A Phase I/II trial of ATI-2231 with Phase Ia in advanced soild tumor malignancies followed by Phase Ib/II in combination with capecitabine in patients with hormone receptor-positive (HR+) and HER16
#14. Determining how prostate cancer cell heterogeneity promotes bone metastasis using fluid-walled microfluidics15
Incidence and radiotherapy treatment patterns of complicated bone metastases15
Long-term oncological and functional outcomes in patients with bone sarcomas in the proximal femur undergoing unplanned surgery: A single-center retrospective cohort study15
Targeting stromal p38MAPKalpha triggers innate-adaptive anti-tumor immunity and sensitizes metastatic breast cancer to immunotherapy14
Impact of myosteatosis on prognosis in multiple myeloma patients: A subgroup analysis of 182 cases and development of a nomogram14
Molecular imaging of bone metastasis14
From imaging to omics: deep learning is bridging MRI and liquid biopsy in bone tumor diagnosis13
FemurTumorNet: Bone tumor classification in the proximal femur using DenseNet model based on radiographs13
LncRNA SATB2-AS1 promotes tumor growth and metastasis and affects the tumor immune microenvironment in osteosarcoma by regulating SATB213
Immune checkpoint inhibitors in bone metastasis: Clinical challenges, toxicities, and mechanisms13
Reprogramming of glucose metabolism: Metabolic alterations in the progression of osteosarcoma13
The roles of the FL/FLT3 axis in the development of cancer-induced bone pain mediated by prostate cancer12
The impact of comprehensive local therapy on treatment outcomes of non-small cell lung cancer with solitary skeletal oligometastasis11
#51. High dimensional profiling of human prostate metastatic bone marrow microenvironment using mass cytometry11
#50. Investigating the role of EphA2 in breast cancer bone metastasis11
Molecular pathological insights into tumorigenesis and progression of giant cell tumor of bone11
Latest developments in the pathobiology of Ewing sarcoma11
#8. Radium-223 treated primary patient bone biopsy analysis: Macro to microscale analyses and dosimetry11
#7. Downstream effects of Gli2 targeting on tumor-immune cell crosstalk in bone metastatic breast cancer11
YBX1-interacting small RNAs and RUNX2 can be blocked in primary bone cancer using CADD52211
Multicenter study on atypical femoral fractures in patients with bone metastases taking bone- modifying agents11
Mixed reality infrastructure based on deep learning medical image segmentation and 3D visualization for bone tumors using DCU-Net11
Automatic classification of spinal osteosarcoma and giant cell tumor of bone using optimized DenseNet11
#45. Fatty acid binding proteins may modulate myeloma in Fabp4/5 double knockout mouse11
COPB2 as a key regulator of cell growth in human osteosarcoma cells: Potential therapeutic target and prognostic indicator10
Treatment of myeloma bone disease: When, how often, and for how long?10
Pexmetinib suppresses osteoclast formation and breast cancer induced osteolysis via P38/STAT3 signal pathway10
Bones and guts – Why the microbiome matters10
Efferocytosis-associated transcriptomic patterns characterize prognosis and immune landscape in osteosarcoma10
Bone metastasis in colorectal cancer: Pathophysiology, prognostic factors, survival outcomes, and treatment strategies – A comprehensive review10
Health- related quality of life after surgery for spinal metastases10
Yin Yang 1 protein-activated N-acetyltransferase 10 drives cell malignant progression of osteosarcoma through ac4C acetylation of integrin β39
Circ_0051079 silencing inhibits the malignant phenotypes of osteosarcoma cells by the TRIM66/Wnt/β-catenin pathway in a miR-625-5p-dependent manner9
Cav3.2 T-Type calcium channels downregulation attenuates bone cancer pain induced by inhibiting IGF-1/HIF-1α signaling pathway in the rat spinal cord9
Luteolin attenuates the chemoresistance of osteosarcoma through inhibiting the PTN/β-catenin/MDR1 signaling axis by upregulating miR-3849
A novel adjunctive diagnostic method for bone cancer: Osteosarcoma cell segmentation based on Twin Swin Transformer with multi-scale feature fusion9
Non-POEMS osteosclerotic multiple myeloma: Clinical characteristics and differential diagnosis9
Tenosynovial giant cell tumor of the hip: a systematic review and institutional case series with Meta-analysis of recurrence and patient-reported outcomes9
Does liquid nitrogen recycled autograft for treatment of bone sarcoma impact local recurrence rate? A systematic review9
Dual-target neoadjuvant therapy with denosumab and sunitinib for giant cell tumor of bone: a sarcoma center experience9
Deep hashing and attention mechanism-based image retrieval of osteosarcoma scans for diagnosis of bone cancer9
The metastatic role of the CXCL10-CXCR3 axis and its therapeutic potential in osteosarcoma8
RGS1 stabilized by METTL3-mediated m6A modification promotes the tumorigenicity and macrophage M2 polarization in osteosarcoma8
Radiographic imaging and diagnosis of spinal bone tumors: AlexNet and ResNet for the classification of tumor malignancy8
Surgical Options for Aggressive Vertebral Hemangiomas：A case series, literature review and treatment recommendations8
Multimodal deep learning for bone tumor diagnosis with clinical imaging, pathology, and blood biomarkers8
Feasibility and oncologic outcome of En bloc resection with intentional tumor transgression in primary spinal sarcoma: The Korean Society of Spinal Tumors multicenter study (KSST 2024–02)8
Malignant and metastatic giant cell tumors of bone; clinical course of primary or secondary malignant and pulmonary metastatic variants8
Diagnostic value of H3F3A mutation and clinicopathological features of giant cell tumours in non-long bones8
Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma8
Abaloparatide and paclitaxel combination therapy Improves bone volume and tumor burden in Bone-Metastatic breast cancer8
An enhanced AlexNet-Based model for femoral bone tumor classification and diagnosis using magnetic resonance imaging7
Determinants of tumor necrosis and its impact on outcome in patients with Localized osteosarcoma uniformly treated with a response adapted regimen without high dose Methotrexate– A retrospective insti7
Diagnosis of newly developed multiple myeloma without bone disease detectable on conventional computed tomography (CT) scan by using dual-energy CT7
The 100 most cited papers on bone metastasis: A bibliometric analysis7
Analysis of morbidity and mortality in patients with primary bone tumors who underwent sacrectomy: A systematic review7
Chronic kidney disease and denosumab in metastatic bone disease: A multicenter Turkish cohort study on severe hypocalcemia, skeletal events, and survival7
Osteofibrous dysplasia, osteofibrous Dysplasia-Like adamantinoma, and adamantinoma: A Single-center retrospective analysis7
#13. 3D printed bioactive glasses porous scaffolds with high strength for the repair of long-bone segmental defects7
Auxiliary diagnosis of primary bone tumors based on Machine learning model7
Groenlandicine enhances cisplatin sensitivity in cisplatin-resistant osteosarcoma cells through the BAX/Bcl-2/Caspase-9/Caspase-3 pathway7
The role of IL-1B in breast cancer bone metastasis7
Pharmacologic Hedgehog inhibition modulates the cytokine profile of osteolytic breast cancer cells7
0.48398208618164